𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy advances in head and neck oncology

✍ Scribed by Dr. William Liggett Jr; Arlene A. Forastiere


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
827 KB
Volume
11
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Docetaxel, cisplatin, and fluorouracil i
✍ David J. Adelstein; James Moon; Ehab Hanna; P. G. Shankar Giri; Glenn M. Mills; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

## Abstract ## Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining 3‐drug taxane‐containing induction chemotherapy with accelerated fractionation/conc

Advances in head and neck oncology
✍ Maisie Shindo πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 2 views
Photo-chemotherapy in advanced head and
✍ Jacobs, John R. ;Weaver, Arthur ;Ahmed, Khurshid ;Crissman, John ;Ensley, John F πŸ“‚ Article πŸ“… 1987 πŸ› Wiley (John Wiley & Sons) βš– 526 KB

Induction (proto) chemotherapy consisting of 3 courses of cisplatin and 120-hour 5-fluorouracil infusion was administered to 88 patients who had locally advanced, previously untreated head and neck cancer. The majority (81%) of these patients were classified as stage IV, and 17% had second primary c